etonpharma.com is a domain that was created on 2013-12-29,making it 12 years ago.
Discover etonpharma.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
| HomePage size: 57.016 KB |
| Page Load Time: 0.500697 Seconds |
| Website IP Address: 34.83.199.149 |
| Aridis Pharmaceuticals - Welcome |
| Clinical Trials | Regeneron Pharmaceuticals |
| Investor Relations :: CNS Pharmaceuticals, Inc. (CNSP) |
| Mirum Pharmaceuticals, Inc. - Investor Relations |
| The Power of the Microbiome | Ferring Pharmaceuticals |
| Investor Relations - Supernus Pharmaceuticals |
| Amneal Pharmaceuticals, Inc. - Investor Relations |
| Investors :: Conatus Pharmaceuticals Inc. (CNAT) |
| Eagle Pharmaceuticals Investor Center | |
| Alcon Completes Acquisition of Aerie Pharmaceuticals | Alcon.com |
| Investor Relations - Spectrum Pharmaceuticals, Inc. |
| TopRx – Home – National Supplier of Generic Pharmaceuticals |
| Ligand Pharmaceuticals Incorporated - Investor Relations |
| Ironwood Pharmaceuticals, Inc. - Company Overview |
| Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC |
| Eton Pharmaceuticals | https://www.etonpharma.com/ |
| Eton Pharmaceuticals, Inc.: Investor Relations https://ir.etonpharma.com/ |
| Company https://www.etonpharma.com/company/ |
| Products | Eton Pharmaceuticals https://www.etonpharma.com/products/ |
| Pipeline https://www.etonpharma.com/pipeline/ |
| Partnerships https://www.etonpharma.com/partnerships/ |
| Leadership Team | Eton Pharmaceuticals https://www.etonpharma.com/leadership-team/ |
| Contact | Eton Pharmaceuticals https://www.etonpharma.com/contact/ |
| Careers https://www.etonpharma.com/careers/ |
| News Releases | Eton Pharmaceuticals, Inc. https://ir.etonpharma.com/news-releases |
| Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-reports-third-quarter-2022-financial |
| Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare ... https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-announces-acquisition-fda-approved-ultra |
| Eton Pharmaceuticals Reports Fourth Quarter 2021 Financial Results https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-reports-fourth-quarter-2021-financial |
| Business Model | Eton Pharmaceuticals https://www.etonpharma.com/business-model/ |
| Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide ... https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-announces-fda-approval-zonisadetm |
| A etonpharma.com. 598 IN A 34.83.199.149 |
| MX etonpharma.com. 3600 IN MX 0 etonpharma-com.mail.protection.outlook.com. |
| NS etonpharma.com. 3600 IN NS ns01.domaincontrol.com. |
| TXT etonpharma.com. 3600 IN TXT adobe-sign-verification=2e9bf536e74abc22ba4f1f724368eacf |
| SOA etonpharma.com. 3600 IN SOA ns01.domaincontrol.com. dns.jomax.net. 2024040100 28800 7200 604800 600 |
| Server: nginx |
| Date: Sun, 12 May 2024 23:42:13 GMT |
| Content-Type: text/html; charset=UTF-8 |
| Content-Length: 49426 |
| Connection: keep-alive |
| Keep-Alive: timeout=20 |
| Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie |
| Link: https://www.etonpharma.com/wp-json/; rel="https://api.w.org/", https://www.etonpharma.com/wp-json/wp/v2/pages/50727; rel="alternate"; type="application/json", https://www.etonpharma.com/; rel=shortlink |
| X-Powered-By: WP Engine |
| X-Cacheable: SHORT |
| Cache-Control: max-age=600, must-revalidate |
| Accept-Ranges: bytes |
| X-Cache: HIT: 4 |
| X-Cache-Group: normal |
| charset="utf-8"/ |
| content="IE=edge" http-equiv="X-UA-Compatible"/ |
| content="max-image-preview:large" name="robots" |
| content="Divi v.4.9.4" name="generator"/ |
| content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" name="viewport"/ |
| content="https://www.etonpharma.com/wp-content/uploads/2021/05/cropped-favicon-270x270.png" name="msapplication-TileImage"/ |
| Ip Country: United States |
| City Name: The Dalles |
| Latitude: 45.6056 |
| Longitude: -121.1807 |
News Contact Company Leadership Team Board of Directors Careers Mission Products Alkindi Sprinkle ® Betaine Anhydrous Carglumic Acid Royalty Products Pipeline Partnerships Business Model Investors News Releases Events & Presentations Stock Information Corporate Governance SEC Filings Contact IR News Contact Finding opportunity in the rarest of places. At Eton, we search the world over for meaningful therapies that we can bring to patients living with rare diseases. Get to know us News View allINVESTOR UPDATE Explore Eton’s diversified pipeline of product candidates under development Learn moreBUSINESS MODEL We select products for rapid commercialization that already have a start. Learn moreOffering real hope is an audacious mission —and we’re succeeding. INSPIRATION Making a profoundly positive impact on the lives of the few. Learn about our mission PARTNERSHIPS Discovering and developing therapies that make a big difference to small populations. Learn how we do it PRODUCTS Bringing multiple approvals to market in just 4 years, with more in the pipeline. Explore our portfolio INVESTORS A rare opportunity to change lives. Together, we can put our care, expertise, and resources to work, providing long-needed treatments to underserved populations. Invest with Eton LEADERSHIP No small feat. Eton provides a rare combination of courage, agility, and the proven ability to execute—clinical trials through commercialization. Meet the team Company Mission Products Partnerships Investors News Contact Privacy Policy Terms & Conditions Email Linkedin 21925 W. Field Pkwy #235 Deer Park, IL 60010 (847) 787-7361 ©2023 Eton Pharmaceuticals. All rights reserved....
Domain Name: ETONPHARMA.COM Registry Domain ID: 1840758527_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2023-12-30T18:03:29Z Creation Date: 2013-12-29T21:40:54Z Registry Expiry Date: 2024-12-29T21:40:54Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS01.DOMAINCONTROL.COM Name Server: NS02.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T17:15:16Z <<<